2023 was a big year for CRISPR-based gene editing but challenges remain
おはこんにちこんばんわっス!
今日はこんな情報を仕入れたっス!
詳しい情報はここにあるから、よーく目を通すっス!
2023 was an important year for patients with sickle cell disease. Prior to CRISPR, the only cure for the life-long ailment was a bone marrow transplan…
▼続きが気になったら元記事をチェックっス
【投稿元】engadget日本語 : 2023 was a big year for CRISPR-based gene editing but challenges remain